Aapro MS - Search Results

1

Antiemetic guidelines: creating a more practical treatment approach.

Koeller JM, Aapro MS, Gralla RJ, Grunberg SM, Hesketh PJ, Kris MG, Clark-Snow RA. Koeller JM, et al. Among authors: aapro ms. Support Care Cancer. 2002 Oct;10(7):519-22. doi: 10.1007/s00520-001-0335-y. Epub 2002 Feb 21. Support Care Cancer. 2002. PMID: 12324805

2

Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.

Einhorn LH, Rapoport B, Koeller J, Grunberg SM, Feyer P, Rittenberg C, Aapro M. Einhorn LH, et al. Support Care Cancer. 2005 Feb;13(2):112-6. doi: 10.1007/s00520-004-0704-4. Epub 2004 Oct 9. Support Care Cancer. 2005. PMID: 15480812 Review.

3

Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy.

Hesketh PJ, Aapro M, Street JC, Carides AD. Hesketh PJ, et al. Support Care Cancer. 2010 Sep;18(9):1171-7. doi: 10.1007/s00520-009-0737-9. Epub 2009 Sep 12. Support Care Cancer. 2010. PMID: 19756774 Clinical Trial.

4

Antiemetic research: future directions.

Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G. Olver I, et al. Support Care Cancer. 2011 Mar;19 Suppl 1:S49-55. doi: 10.1007/s00520-010-1036-1. Epub 2010 Nov 10. Support Care Cancer. 2011. PMID: 21063733

5

Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).

Roila F, Warr D, Aapro M, Clark-Snow RA, Einhorn L, Gralla RJ, Herrstedt J, Saito M, Tonato M. Roila F, et al. Support Care Cancer. 2011 Mar;19 Suppl 1:S57-62. doi: 10.1007/s00520-010-1039-y. Epub 2010 Dec 5. Support Care Cancer. 2011. PMID: 21132332

6

2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.

Roila F, Warr D, Hesketh PJ, Gralla R, Herrstedt J, Jordan K, Aapro M, Ballatori E, Rapoport B. Roila F, et al. Support Care Cancer. 2017 Jan;25(1):289-294. doi: 10.1007/s00520-016-3365-1. Epub 2016 Aug 11. Support Care Cancer. 2017. PMID: 27510316

7

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.

Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS. Herrstedt J, et al. Among authors: aapro ms. Support Care Cancer. 2017 Jan;25(1):277-288. doi: 10.1007/s00520-016-3313-0. Epub 2016 Jul 22. Support Care Cancer. 2017. PMID: 27443154 Review.

8

Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.

Hesketh PJ, Schnadig ID, Schwartzberg LS, Modiano MR, Jordan K, Arora S, Powers D, Aapro M. Hesketh PJ, et al. Cancer. 2016 Aug 1;122(15):2418-25. doi: 10.1002/cncr.30054. Epub 2016 May 13. Cancer. 2016. PMID: 27176138 Free PMC article. Clinical Trial.

9

A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting.

Hesketh PJ, Aapro M, Jordan K, Schwartzberg L, Bosnjak S, Rugo H. Hesketh PJ, et al. Biomed Res Int. 2015;2015:651879. doi: 10.1155/2015/651879. Epub 2015 Sep 3. Biomed Res Int. 2015. PMID: 26421300 Free PMC article. Review.

10

Proposal for classifying the acute emetogenicity of cancer chemotherapy.

Hesketh PJ, Kris MG, Grunberg SM, Beck T, Hainsworth JD, Harker G, Aapro MS, Gandara D, Lindley CM. Hesketh PJ, et al. Among authors: aapro ms. J Clin Oncol. 1997 Jan;15(1):103-9. doi: 10.1200/JCO.1997.15.1.103. J Clin Oncol. 1997. PMID: 8996130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters